Longwood Fund — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Alcyone TherapeuticsNov 2023SEC filingmedium confidence
HealthtechLowell, US
PJ Anand(Executive Officer, Director)
BoardEdgar D. Jannotta(Director)Edgar Jannotta, Jr.(Director)Norbert Riedel(Director)Stephen Oesterle(Director)
Board seatDavid Donabedian· per SEC Form D · $31.6M raise · filed Jan 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.